Dr. Samuel Robert Beckerman, MD, PhD

Dr. Beckerman practices at Huntington Hospital - Unit in Pasadena, California.

Dr. Beckerman's NPI, 1407387475, was assigned on March 22, 2017. Dr. Beckerman graduated from University of Miami, Miller School of Medicine in 2017. Dr. Beckerman holds California license A157860.

Dr. Beckerman's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Dr. Beckerman's primary practice is Huntington Hospital - Unit in Pasadena, California. Dr. Beckerman is also affiliated with Huntington Hospital. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Beckerman to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beckerman practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Beckerman's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Beckerman is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Beckerman is licensed in California.

CMS data shows 794 Medicare services from Dr. Beckerman across 7 procedure codes in 2024, for 501 Medicare patients. Medicare paid $58,084 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 501 Medicare patients who saw Dr. Beckerman in 2024. The largest group is 75 to 84, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beckerman's median patient age at 51, with 54% women.

In 2024, Dr. Beckerman wrote 583 Medicare Part D claims for 310 patients. 94% of them were for generic drugs. CMS names the drug for 396 of them, across 15 drugs with 11 or more claims each, at $2,441 in total drug cost. In 2023, CMS named 253 claims across 12 drugs.

Dr. Beckerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Beckerman, published from 2013 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Axons and Nerve Regeneration. Dr. Beckerman has published most often in Exp Neurol. Dr. Beckerman's most frequent co-authors are Malcolm R. Bullock, MD, Ryan Seiji Kitagawa, MD and Dana Rodney Sajed, MD.

CMS Open Payments shows 5 general payments to Dr. Beckerman from 2 drug and device companies from 2022 to 2024. Consulting fees make up the largest share, 100% of the total. Ceribell, Inc. paid the most, $80,543.

Dr. Beckerman graduated from University of Miami, Miller School of Medicine in 2017.

Dr. Beckerman is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.